# PharmaWatch: Output & UX Specification

**Version:** 1.0  
**Status:** Final Draft  
**Objective:** To define the intelligence products and user interaction models that transform fragmented pharmaceutical data into actionable strategic insights.

---

## 1. Intelligence Products

### 2.1 Daily Signal Briefs
*Automated, high-level synthesis of the previous 24 hours of sector activity.*

| Component | Specification |
| :--- | :--- |
| **User Persona** | **Market Analysts & Senior Clinical Leads**: Professionals needing a curated "morning briefing" to prioritize their daily agenda without manual searching. |
| **Core Value Prop** | **Information Synthesis**: Converts noise from hundreds of daily sources into a prioritized summary of critical movements. |
| **Key Data Inputs** | Regulatory filings (FDA/EMA), ClinicalTrials.gov updates, major industry news, and pharmaceutical earnings reports. |
| **Delivery Format** | Email Digest (HTML), Slack/Microsoft Teams summary, and a dedicated "Daily Brief" landing page in the Web Dashboard. |
| **Critical UX Requirements** | • **Hierarchical Scannability:** Summary $\rightarrow$ Key Bullet Points $\rightarrow$ Deep-Dive Details.<br>• **Direct Source Provenance:** Every bullet point must contain a hyperlink to the primary source document.<br>• **Topic Filtering:** Ability to customize briefings based on therapeutic area (e.g., Oncology, Immunology) or specific competitor lists. |

### 2.2 Real-time Alerting
*Low-latency, trigger-based notifications for high-impact, time-sensitive events.*

| Component | Specification |
| :--- | :--- |
| **User Persona** | **Regulatory Compliance Officers & Safety Monitors**: Individuals responsible for immediate response to safety signals, recalls, or sudden regulatory shifts. |
| **Core Value Prop** | **Minimized Latency**: Reduces the gap between a critical event occurring and the organization taking defensive or proactive action. |
| **Key Data Inputs** | Breaking news wires, social media sentiment spikes, emergency regulatory announcements, and adverse event reporting streams. |
| **Delivery Format** | Push notifications (Mobile), SMS, Slack/Teams alerts, and Webhooks for automated enterprise workflow integration. |
| **Critical UX Requirements** | • **Urgency Tiering:** Visual and auditory distinction based on severity (e.g., Red for "Critical/Safety," Amber for "Regulatory Shift").<br>• **Contextual Snippets:** An immediate "Impact Summary" (e.g., *"Why this matters: Potential delay in Phase III approval for [Drug X]"*).<br>• **Verification Shortcut:** A "View Source" button that opens the raw document in a side-pane without leaving the alert view. |

### 2.3 Trend Dashboards
*Visualized, long-term analysis of data patterns and landscape shifts.*

| Component | Specification |
| :--- | :--- |
| **User Persona** | **Strategic Planners & R&D Directors**: Decision-makers identifying long-term investment, partnership, or pipeline opportunities. |
| **Core Value Prop** | **Pattern Recognition**: Converts massive longitudinal datasets into visual narratives, revealing shifts in therapeutic dominance or emerging competitor clusters. |
| **Key Data Inputs** | Aggregated clinical trial history, patent filing trends, academic publication volumes, and historical market pricing. |
| **Delivery Format** | Interactive Web Dashboard. |
| **Critical UX Requirements** | • **Multi-Dimensional Drill-Down:** Users must be able to click any data point on a trend line to reveal the specific entities (drugs, companies, molecules) driving that trend.<br>• **Comparative Viewports:** Capability to overlay disparate datasets (e.g., *"Oncology Clinical Trial Starts"* overlaid with *"Oncology Patent Expirations"*).<br>• **AI-Driven Insight Layers:** Automatic annotations on charts highlighting statistical anomalies or significant inflection points. |

### 2.4 Semantic Search Interface
*Natural language querying across the entire PharmaWatch knowledge base.*

| Component | Specification |
| :--- | :--- |
| **User Persona** | **Medical Science Liaisons (MSLs) & Intelligence Analysts**: Power users conducting deep-dive investigations into specific molecules, diseases, or competitors. |
| **Core Value Prop** | **Intelligent Discovery**: Eliminates the need for complex Boolean queries, allowing users to ask complex questions and receive synthesized answers. |
| **Key Data Inputs** | The entire indexed PharmaWatch corpus (News, Trials, Patents, Regulatory, etc.). |
| **Delivery Format** | Conversational Web Interface (Chat/Search hybrid). |
| **Critical UX Requirements** | • **Citation-First Architecture:** Every synthesized answer must include inline, clickable citations to the source documents used.<br>• **Reasoning Transparency:** An "Explain Logic" toggle that reveals the specific data points and entities the AI used to formulate its answer.<br>• **Guided Exploration:** Intelligent "Next Question" suggestions based on the current conversation to guide deeper investigation. |

---

## 3. Universal UX Principles

1.  **Trust through Transparency:** Every AI-generated insight must be explicitly labeled and linked to raw, verifiable data. We prioritize "Verifiable Intelligence" over "Black Box Synthesis."
2.  **Action-Oriented Design:** Every piece of intelligence must answer the user's implicit question: *"So what?"* Interfaces should always provide a clear next step (e.g., "Investigate Source," "Alert Team," "Download Report").
3.  **Minimalist Density (Progressive Disclosure):** Pharma data is inherently dense. The UI must remain clean, using progressive disclosure to reveal complexity only when the user requests more depth.
4.  **Persona-Centric Delivery:** Information should meet the user where they are (Slack, Email, or Dashboard) in the format most appropriate for their specific decision-making cycle.
